Skip to main content
Neal Benowitz, MD, Internal Medicine, San Francisco, CA

NealLeonBenowitzMD

Internal Medicine • San Francisco, CA

Professor, Medicine, UCSF School of Medicine

Join to view full profile

Dr. Benowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Benowitz's full profile

Already have an account?

  • Office

    1001 Potrero Ave
    Rm 5g1
    San Francisco, CA 94110
    Phone+1 415-206-3503
    Fax+1 415-206-5100

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1971 - 1974
  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1969 - 1971
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1969

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1971 - 2025
  • FL State Medical License
    FL State Medical License 2011 - 2016
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1988

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Butanediol Conversion to Gamma‐Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole  
    Neal L Benowitz, Hallam Gugelmann, Delia A Dempsey, Clinical Pharmacology & Therapeutics
  • Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking Following Abstinence  
    Delia A Dempsey, Neal L Benowitz, Clinical Pharmacology & Therapeutics
  • Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke ExposureA Randomized Clinical Trial  
    Paul M Cinciripini, Stephen S Hecht, F Joseph McClernon, Neal L Benowitz, Sharon S Allen, JAMA
  • Join now to see all

Lectures

  • Randomized Within‐Subject Trial to Evaluate Smokers’ Initial Perceptions, Subjective Effects, and Nicotine Delivery Across Six Vaporized Nicotine Products 
    University of California, San Francisco, California - 12/16/2011
  • Randomized Within‐Subject Trial to Evaluate Smokers’ Initial Perceptions, Subjective Effects, and Nicotine Delivery Across Six Vaporized Nicotine Products 
    American Society of Addiction Medicine, San Francisco, California - 9/5/2012

Press Mentions

  • Top Tobacco Control Experts Endorse Vaping
    Top Tobacco Control Experts Endorse VapingAugust 30th, 2021
  • Thirdhand Smoke Impacts Gut Bacteria for Infants, Study Finds
    Thirdhand Smoke Impacts Gut Bacteria for Infants, Study FindsMay 26th, 2021
  • The Health 202: FDA Could Begin Ramping up Tobacco Regulation Efforts
    The Health 202: FDA Could Begin Ramping up Tobacco Regulation EffortsMay 24th, 2021
  • Join now to see all

Grant Support

  • Mechanisms Of The Nicotine Metabolism Effect On Tobacco DependenceNational Institute On Drug Abuse2012
  • University Of California, SAN Francisco (UCSF)National Institute On Drug Abuse2010–2011
  • Laboratory ResourceNational Institute On Drug Abuse2010–2011
  • Drug Dependence Clinical Research ProgramNational Institute On Drug Abuse2010–2011
  • Tobacco Control ProgramNational Cancer Institute2007–2011
  • Pharmacokinetics And Pharmacodynamics Of NicotineNational Institute On Drug Abuse1985–2011
  • Leadership CoreNational Institute On Drug Abuse2007–2009
  • Clinical CoreNational Institute On Drug Abuse2007–2009
  • Pharmacogenetics Of Nicotine Addiction And TreatmentNational Institute On Drug Abuse2005–2009
  • Clinical Pharmacology, Drug Action &PharmacogeneticsNational Institute Of General Medical Sciences2005–2009
  • Safety Of Nicotine Reduction StrategyNational Cancer Institute2004–2009
  • Core--ClinicalNational Institute On Drug Abuse2005–2006
  • Project 1 (Leadership Core)National Institute On Drug Abuse2005
  • Effects Of Grapefruit Juice On Oral Nicotine PharmacokineticsNational Center For Research Resources2005
  • Cardiovascular Effects Of Cigarette Smoking Compared To Transdermal NicotineNational Center For Research Resources2005
  • Vasoactive Substances In BP DysregulationNational Center For Research Resources2004–2005
  • Pharmacogenetic Study Of Nicotine MetabolismNational Center For Research Resources2004–2005
  • Menthol Cigarettes And Nitrosamine MetabolismNational Center For Research Resources2004–2005
  • Ethnic Differences Of Nicotine In Non-SmokersNational Center For Research Resources2004–2005
  • Effects Of Nicotine On Drug MetabolismNational Center For Research Resources2004–2005
  • Biochemical Assessment Of Low Level Nicotine ExposureNational Center For Research Resources2004–2005
  • Clinical, Pharmacology, Drug Action &PharmacokineticsNational Institute Of General Medical Sciences2000–2004
  • Nicotine Kinetics In TwinsNational Center For Research Resources1999–2002
  • Effects Of Mecamylamine On Nicotine Disposition &PharmacodynamicsNational Center For Research Resources1999–2002
  • Safety Of A Nicotine Reduction StrategyNational Cancer Institute1999–2002
  • Mentholated Cigarettes And Nicotine MetabolismNational Center For Research Resources1998–2002
  • Effects Of Menstrual Cycle On Metabolism And Effects Of NicotineNational Center For Research Resources1998–2002
  • Vasoactive Substances In Blood Pressure Dysregulation SyndromesNational Center For Research Resources1997–2002
  • Metabolism And Clearance Of Nicotine In Pregnant WomenNational Center For Research Resources1996–2002
  • Stable Isotope Studies Of Nicotine And Cotinine MetabolismNational Center For Research Resources1995–2002
  • Pharmacokinetics And Pharmacodynamics Of NicotineNational Institute On Drug Abuse1993–2002
  • Disposition Kinetics &Effects Of MentholNational Center For Research Resources1999–2000
  • Effect Of Cotinine On Nicotine MetabolismNational Center For Research Resources1996–1999
  • Dihydroergotamine Treatment For Severe Orthostatic HypotensionNational Center For Research Resources1995–1999
  • Clinical Pharmacology, Drug Action &PharmacokineticsNational Institute Of General Medical Sciences1985–1999
  • The Clinical Pharmacology Of CaffeineNational Institute On Drug Abuse1996–1998
  • Caffeine Consumption And Opiate Withdrawl Symptoms During Methadone MaintenanceNational Center For Research Resources1997
  • Dose Related Effects Of Transdermal NicotineNational Center For Research Resources1996–1997
  • Arteriovenous Differences In Plasma Nicotine ConcentrationsNational Center For Research Resources1996–1997
  • Nicotine Metabolism In PregnancyNational Institute On Drug Abuse1995–1997
  • Substances In Blood Pressure Dysregulation SyndromesNational Center For Research Resources1996
  • Coumarin Metabolism As A Probe For CPY 2A6 ActivityNational Center For Research Resources1996
  • Intake Of Nicotine-Related Alkaloids By Smokers And Smokeless Tobacco UsersNational Center For Research Resources1995–1996
  • Chronopharmacokinetics Of NicotineNational Center For Research Resources1995–1996
  • Clinical Pharmacology Drug Action &PharmacokineticsNational Institute Of General Medical Sciences1993–1996
  • Substances In Blood Pressure Dysregulation SyndromeNational Center For Research Resources1995
  • Pharmacokinetics Of Subcutaneous Nicotine In Smokers And NonsmokersNational Center For Research Resources1995
  • Pharmacokinetics Of Subcutaneous Nicotine In SmokersNational Center For Research Resources1995
  • Pharmacodynamics Of Nicotine--Importance Of Rate Of DosingNational Center For Research Resources1995
  • Clinical Pharmacology Of Trans-3'-HydroxycotinineNational Center For Research Resources1995
  • Caffeine Consumption In Opiate AddictsNational Center For Research Resources1995
  • Pharmacokinetics &Pharmacodynamics Of NicotineNational Institute On Drug Abuse1988–1992
  • Clinical Pharmacology, Drug Action And PharmacokineticsNational Institute Of General Medical Sciences1987–1992
  • Nicotine And TAR Intake During Cigarette SmokingNational Cancer Institute1985–1988
  • Pharmacology Of Nicotine In Human Cardiovascular DiseaseNational Heart, Lung, And Blood Institute1985
  • Urinary PH In Cigarette SmokingNational Center For Research Resources1985
  • Serum Thiocynate In Non-SmokersNational Center For Research Resources1985
  • Reversal Of Opiate Withdrawal Using Alpha-MethyldopaNational Center For Research Resources1985
  • Pharmacokinetics Of Nicotine In Disease StatesNational Center For Research Resources1985
  • Pharmacokenetic And Pharmacodynamics Of Quinidine And MetabolitesNational Center For Research Resources1985
  • Nicotine And TAR Intake While Smoking Different Numbers Of CigarettesNational Center For Research Resources1985
  • Nicotine And TAR Intake From Tobacco ProductsNational Center For Research Resources1985
  • Nicotine And Catecholamine Concentrations In Human BloodNational Center For Research Resources1985
  • Metabolism And Effect Of Nicotine And CotinineNational Center For Research Resources1985
  • Lidocaine Therapy For Refractroy Status EpilepticusNational Center For Research Resources1985
  • Effects Of Tobacco Abstinence On NicotineNational Center For Research Resources1985
  • Effect Of Nicotine Gum On Nicotine And TAR Intake During SmokingNational Center For Research Resources1985
  • Diurnal Studies Of Nicotine Blood Level And CV Effect During SmokingNational Center For Research Resources1985
  • Dihydroergotamine Treatment For Orthostatic HypotensionNational Center For Research Resources1985
  • Cigarette Smoking, Nicotine And CoagulationNational Center For Research Resources1985

Dr. Neal Benowitz, Dr. Neal Benowitz, MD, Dr. N Benowitz, Dr. Neal Leon Benowitz